Plexium Selects Xavo as their Sample Management Lab Operations Platform
July 24, 2024 – Biotechnology, Drug Discovery, Pharmaceutical – Plexium, Targeted Protein Degradation, Xavo, research and development, sample management lab operations platform
24 July 2024 — Massachusetts, US — Xavo, a leading provider of innovative software solutions for life sciences R&D, proudly announces Plexium as its latest esteemed client.
“We are thrilled to welcome Plexium to the Xavo family. The collaboration between the two companies marks a significant milestone in Xavo’s journey. We stay committed to deliver cutting-edge technology, tailored to meet the evolving needs of R&D labs worldwide,” says Gabriel Petrescu, Xavo’s VP of Business Development.
Plexium, a biopharmaceutical company based in San Diego, California, US, specialises in next-generation targeted protein degradation modalities for the treatment of cancer, neurodegeneration and other diseases. “I was on a tight timeline when searching for a new sample management software partner,” says Nicole Anderson, head of Compound Management at Plexium. She continues: “I was impressed by the calibre of the Xavo team and their excitement about the recent innovations in their software. Since launching Xavo, even complex workflows execute efficiently.”
Leveraging Xavo’s rapid deployment capabilities, comprehensive out-of-the-box product functionality and preconfigured integrations, the joint team successfully launched the sample management platform within a short timeframe.
“At Xavo, we take pride in demonstrating our ability to successfully deliver our solutions quickly even under stringent time constraints. Configuration and implementation of the Xavo R3 platform is a matter of days to weeks rather than months. The successful deployment at Plexium demonstrates the maturity of our product and the agility of our processes” says Florian Tauchert, Xavo’s managing director.
About the Xavo platform
Xavo R3 is a full-featured Sample Management and Lab Operations platform for Biopharma R&D labs that is exclusively offered as Software-as-a-Service. Xavo R3 tackles the dynamic challenges of today’s labs by using extendable business rules, algorithmic intelligence for lab equipment usage optimisation as well as guided workflow support that prioritises material use, throughput, cycle time and resource efficiency. Our machine learning algorithms ensure precise scheduling and quick issue resolution for streamlined workflows, making Xavo R3 the copilot for Life Sciences R&D labs.
About Xavo
Xavo is a software company that was founded in 2016 with the sole focus on delivering exceptional value to Biopharma R&D through Software-as-a-Service. Xavo has offices in the US, Germany and Switzerland. Visit: https://xavo.com.
